Immune crosstalk driven by osteoclast-like macrophages and CXCR4+ B cells shapes prostate cancer progression via an MIF–IL-10 axis
Background Most primary prostate cancers (PCa) exhibit a slow and indolent progression that is androgen-dependent. However, a subgroup of advanced prostate cancers has aggressive nature and the ability to cause bone metastasis. Metastatic prostate cancer has a profound immunosuppressive tumor microenvironment, which limits the response to immunotherapy. However, how immune remodeling across bone marrow and prostate tissues contributes to tumor progression and metastatic dissemination remains unclear. Methods We integrated six public single-cell RNA sequencing (scRNA-seq) datasets from 60 individuals, including bone marrow aspirates and prostate cancer–related tissues, to characterize immune cell states, developmental trajectories, and intercellular communication during PCa progression. Functional validation was performed using in vitro experiments and an in vivo subcutaneous xenograft tumor model. Results Immune cells displayed marked heterogeneity between bone marrow and prostate tissues during PCa progression, while bone metastases exhibited a transitional immune phenotype. Correlation analysis identified six immune microenvironment subgroups. Among these, an immune subtype dominated by osteoclast-like macrophages (OLMs) was enriched in primary tumors and associated with poor clinical prognosis. Cell–cell communication analysis computationally predicted a macrophage migration inhibitory factor (MIF)–centered signaling axis linking OLMs with CXCR4 + B cells, accompanied by IL-10 upregulation and reduced recurrence-free survival. Functional assays demonstrated that activated CXCR4 + B cells promote prostate cancer cell proliferation, migration, and invasion via an IL-10–dependent pathway. Pharmacological inhibition of CXCR4 or IL-10 partially reversed these tumor-promoting effects in vitro and in a subcutaneous xenograft model. Conclusions These findings identify a compositionally associated and partially functionally validated immune crosstalk axis, which may promote PCa progression via MIF–IL-10 signaling under experimental conditions.
Authors
- Hongjian Song (ORCID: https://orcid.org/0009-0000-1273-1028)
- Zhichao Tong (ORCID: https://orcid.org/0000-0002-2044-5037)
- Haonan Li (ORCID: https://orcid.org/0009-0004-3826-1190)
- Ziyi Liu
- Zongzheng Yang
- Yubo Zhao
- Yaowei Li
- Qing Shi
- Ziqi Wang
- Qian Zhang
- Haoran Zhu
Institutions
- Harbin Medical University (CN)
- Chinese Academy of Sciences (CN)
- TUM Klinikum (DE)
- Third Affiliated Hospital of Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
- University of Chinese Academy of Sciences (CN)
- Technical University of Munich (DE)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3389/fimmu.2026.1881923
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Harbin Medical University
- Innovative Research Group Project of the National Natural Science Foundation of China
- Key Research and Development Program of Heilongjiang
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Heilongjiang Provincial Department of Human Resources and Social Security
- National Key Research and Development Program of China